Trial intelligence / Profile preview

IronMother: Daily versus alternate day oral iron supplementation in pregnancy

2022-001815-25Phase 4Active

Sponsor
University College Dublin
Start
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ferrous fumarate in iron deficiency anemia (IDA) (2 arms), sponsored by University College Dublin. Primary endpoint: Primary: haemoglobin level at 4 weeks. Started May 2022; status: active.

02

Drugs

ferrous fumarate
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on 2022-001815-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2022-001815-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call